摘要
脂类参与淀粉样前体蛋白(APP)的转运和加工-阿尔茨海默病(AD)发病过程中的重要因素,影响神经毒素的形成Cβ-淀粉样蛋白(Aβ)肽。AD脑细胞中ApoE 4蛋白的存在是一个重要的危险因素。此外,脂类信号通路在细胞h中起着至关重要的作用。平衡和依赖于特定的蛋白质-脂质相互作用。本文就膜脂(胆固醇、甘油磷脂、鞘脂)和脂代谢的病理改变作一综述。AD的代谢,并提供了目前对生物膜,其脂质结构和功能的理解,以及他们作为潜在的治疗目标的作用。新方法对膜结构和脂类组成的研究将从广义上进行综述,并对脂类生物标志物在AD早期诊断中的应用作一综述。βPE的相互作用综述了含有细胞膜和不同亚细胞器的肽。接下来,详细介绍最重要的脂类信号通路,包括质膜作为应激物质的作用。文中给出了ENSOR及其治疗应用。摘要4-羟基-2-非肾素可能在AD发病过程中起着特殊的作用,因此,阿尔茨海默病的“钙蛋白酶-组织蛋白酶假说”成为研究热点。爱德。最后,讨论了最重要的脂类饮食因素及其在预防AD中的可能用途和效果。
关键词: 血脂,膜,阿尔茨海默病,脂类Aβ聚集,脂质-蛋白质相互作用,4-羟基-2-非肾,载脂蛋白E,膜脂治疗,脂质饮食因素。
Current Alzheimer Research
Title:The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View
Volume: 15 Issue: 13
关键词: 血脂,膜,阿尔茨海默病,脂类Aβ聚集,脂质-蛋白质相互作用,4-羟基-2-非肾,载脂蛋白E,膜脂治疗,脂质饮食因素。
摘要: Lipids participate in Amyloid Precursor Protein (APP) trafficking and processing - important factors in the initiation of Alzheimer’s disease (AD) pathogenesis and influence the formation of neurotoxic β-amyloid (Aβ) peptides. An important risk factor, the presence of ApoE4 protein in AD brain cells binds the lipids to AD. In addition, lipid signaling pathways have a crucial role in the cellular homeostasis and depend on specific protein-lipid interactions. The current review focuses on pathological alterations of membrane lipids (cholesterol, glycerophospholipids, sphingolipids) and lipid metabolism in AD and provides insight in the current understanding of biological membranes, their lipid structures and functions, as well as their role as potential therapeutic targets. Novel methods for studying the membrane structure and lipid composition will be reviewed in a broad sense whereas the use of lipid biomarkers for early diagnosis of AD will be shortly summarized. Interactions of Aβ peptides with the cell membrane and different subcellular organelles are reviewed. Next, the details of the most important lipid signaling pathways, including the role of the plasma membrane as stress sensor and its therapeutic applications are given. 4-hydroxy-2-nonenal may play a special role in the initiation of the pathogenesis of AD and thus the “calpain-cathepsin hypothesis” of AD is highlighted. Finally, the most important lipid dietary factors and their possible use and efficacy in the prevention of AD are discussed.
Export Options
About this article
Cite this article as:
The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View, Current Alzheimer Research 2018; 15 (13) . https://dx.doi.org/10.2174/1567205015666180911151716
DOI https://dx.doi.org/10.2174/1567205015666180911151716 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Structure – Function Relationships of Pre-Fibrillar Protein Assemblies in Alzheimers Disease and Related Disorders
Current Alzheimer Research Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
Current Pharmaceutical Design Gene Expression Studies in Multiple Sclerosis
Current Genomics Pharmacological Manipulation of Neural Progenitor Pathways In Situ: Possibilities for Neural Restoration in the Injured Adult Brain
Current Medicinal Chemistry - Central Nervous System Agents New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
Current Pharmaceutical Design Alzheimer Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies
CNS & Neurological Disorders - Drug Targets Neurodegeneration and the Heat Shock Protein 70 Machinery: Implications for Therapeutic Development
Current Topics in Medicinal Chemistry Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration
Current Neuropharmacology Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
CNS & Neurological Disorders - Drug Targets Modulation of Neuro-Inflammation and Vascular Response by Oxidative Stress Following Cerebral Ischemia-Reperfusion Injury
Current Medicinal Chemistry Natural Compounds with Proteasome Inhibitory Activity for Cancer Prevention and Treatment
Current Protein & Peptide Science Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and its Analogs
Current Medicinal Chemistry Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain
Current Neuropharmacology Commentary: Neurorestoratology: A Concept and Emerging Discipline in the Treatment of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Bridging Over the Troubled Heterogeneity of SPG-Related Pathologies: Mechanisms Unite What Genetics Divide
Current Molecular Medicine RNAi Silencing in Mouse Models of Neurodegenerative Diseases
Current Drug Delivery Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease
Current Topics in Medicinal Chemistry The Therapeutic Potential of Stem Cells in Amyotrophic Lateral Sclerosis
Current Signal Transduction Therapy